Advances in cancer immunotherapy

被引：36

作者：

Ockert, D ^{[1
]}

Schmitz, M

Hampl, M

Rieber, EP

机构：

[1] Tech Univ Dresden, Dept Surg, D-8027 Dresden, Germany

[2] Tech Univ Dresden, Inst Immunol, Fac Med, D-8027 Dresden, Germany

来源：

IMMUNOLOGY TODAY | 1999年 / 20卷 / 02期

关键词：

D O I：

10.1016/S0167-5699(98)01388-7

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Specific engagement of immune effector functions is a rapidly advancing field within experimental tumor therapy. A recent meeting* focused on the analysis of cellular and humoral immune responses against tumors and on clinical trials of antitumor vaccination and antibody therapy.

引用

页码：63 / 65

页数：3

共 13 条

[1] Dendritic cells and the control of immunity
Banchereau, J
Steinman, RM
[J]. NATURE, 1998, 392 (6673) : 245 - 252
[2] BENNETT SRM, 1998, NAT MED, V1, P478
[3] FROM DEFINED HUMAN TUMOR-ANTIGENS TO EFFECTIVE IMMUNIZATION
BOON, T
GAJEWSKI, TF
COULIE, PG
[J]. IMMUNOLOGY TODAY, 1995, 16 (07): : 334 - 336
[4] Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity
Celluzzi, CM
Mayordomo, JI
Storkus, WJ
Lotze, MT
Falo, LD
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) : 283 - 287
[5] IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES
COX, AL
SKIPPER, J
CHEN, Y
HENDERSON, RA
DARROW, TL
SHABANOWITZ, J
ENGELHARD, VH
HUNT, DF
SLINGLUFF, CL
[J]. SCIENCE, 1994, 264 (5159) : 716 - 719
[6] Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
Hsu, FJ
Benike, C
Fagnoni, F
Liles, TM
Czerwinski, D
Taidi, B
Engleman, EG
Levy, R
[J]. NATURE MEDICINE, 1996, 2 (01) : 52 - 58
[7] BONE-MARROW-DERIVED DENDRITIC CELLS PULSED WITH SYNTHETIC TUMOR PEPTIDES ELICIT PROTECTIVE AND THERAPEUTIC ANTITUMOR IMMUNITY
MAYORDOMO, JI
ZORINA, T
STORKUS, WJ
ZITVOGEL, L
CELLUZZI, C
FALO, LD
MELIEF, CJ
ILDSTAD, ST
KAST, WM
DELEO, AB
LOTZE, MT
[J]. NATURE MEDICINE, 1995, 1 (12) : 1297 - 1302
[8] Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses
Mingari, MC
Moretta, A
Moretta, L
[J]. IMMUNOLOGY TODAY, 1998, 19 (04): : 153 - 157
[9] Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
Nestle, FO
Alijagic, S
Gilliet, M
Sun, YS
Grabbe, S
Dummer, R
Burg, G
Schadendorf, D
[J]. NATURE MEDICINE, 1998, 4 (03) : 328 - 332
[10] A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, JP
Di Rosa, F
Matzinger, P
[J]. NATURE, 1998, 393 (6684) : 474 - 478

← 1 2 →